| Trade Date |
Insider |
Title |
Buy or Sell |
Quantity |
Security Type |
Price |
Proceeds |
Transaction Conviction |
Position Quantity |
Position Value |
Positon Conviction |
SEC Link |
Nature of Ownership |
2020-04-23 | Michael Severino | - | Buy | 10,022 | Common Stock | $0.00 | $0.00 | - | 10,022 | $0.00 | 0.17 [Very Low] | Form 4 | - | 2020-05-17 | Thomas A Szlosek | EVP & CFO | Sell | 21,287 | Common Stock | $17.86 | $380,185.82 | 0.37 [ Average ] | 266,134 | $4,753,153.24 | 4.63 [Low] | Form 4 | - | 2020-05-17 | Christophe Couturier | EVP, Services | Sell | 11,189 | Common Stock | $17.86 | $199,835.54 | 0.19 [ Low ] | 162,932 | $2,909,965.52 | 2.83 [Low] | Form 4 | - | 2020-05-17 | Steven W Eck | SVP & Chief Accounting Officer | Sell | 573 | Common Stock | $17.86 | $10,233.78 | - | 23,483 | $419,406.38 | 0.41 [Very Low] | Form 4 | - | 2020-05-17 | James Bramwell | EVP, Strategic Partners | Sell | 12,102 | Common Stock | $17.86 | $216,141.72 | 0.21 [ Low ] | 127,788 | $2,282,293.68 | 2.22 [Low] | Form 4 | - | 2020-05-17 | Michael Stubblefield | CEO | Sell | 108,700 | Common Stock | $17.86 | $1,941,382.00 | 1.89 [ High ] | 1,266,935 | $22,627,459.10 | 22.04 [High] | Form 4 | - | 2020-05-17 | Eric Mcallister | EVP, CHRO | Sell | 9,155 | Common Stock | $17.86 | $163,508.30 | 0.16 [ Low ] | 197,899 | $3,534,476.14 | 3.44 [Low] | Form 4 | - | 2020-05-17 | Devashish Ohri | EVP, IMEA | Sell | 16,791 | Common Stock | $17.86 | $299,887.26 | 0.29 [ Average ] | 151,671 | $2,708,844.06 | 2.64 [Low] | Form 4 | - | 2020-05-17 | Justin Miller | EVP & General Counsel | Sell | 9,155 | Common Stock | $17.86 | $163,508.30 | 0.16 [ Low ] | 136,394 | $2,435,996.84 | 2.37 [Low] | Form 4 | - | 2020-05-17 | Frederic Vanderhaegen | EVP, Europe | Sell | 2,210 | Common Stock | $17.86 | $39,470.60 | 0.04 [ Very Low ] | 237,431 | $4,240,517.66 | 4.13 [Low] | Form 4 | - | 2020-05-17 | Gerard Brophy | EVP, Biopharma Production | Sell | 13,790 | Common Stock | $17.86 | $246,289.40 | 0.24 [ Low ] | 222,078 | $3,966,313.08 | 3.86 [Low] | Form 4 | - | 2020-05-17 | Michael Wondrasch | EVP & CIO | Sell | 9,155 | Common Stock | $17.86 | $163,508.30 | 0.16 [ Low ] | 177,044 | $3,162,005.84 | 3.08 [Low] | Form 4 | - | 2020-05-20 | Gerard Brophy | EVP, Biopharma Production | Sell | 25,495 | Common Stock | $17.36 | $442,593.20 | 0.44 [ Average ] | 196,583 | $3,412,680.88 | 3.42 [Low] | Form 4 | - | 2020-05-22 | Michael Wondrasch | EVP & CIO | Sell | 22,987 | Common Stock | $17.82 | $409,628.34 | 0.40 [ Average ] | 154,087 | $2,745,830.34 | 2.68 [Low] | Form 4 | - | 2020-05-26 | New Mountain Investments Iii, Llc | - | Sell | 20,886,424 | Common Stock | $15.90 | $332,094,141.60 | 363.29 [ Very High ] | 89,591,565 | $1,424,505,883.50 | 1,558.30 [Very High] | Form 4 | See Footnote | 2019-06-13-04:00 | Goldman Sachs & Co. Llc | - | Buy | 1,133,920 | Common Stock, par value $0.01 per share | $0.00 | $0.00 | - | 72,605,349 | $0.00 | 1,262.86 [Very High] | Form 4 | See Footnotes | 2020-05-26-04:00 | Goldman Sachs & Co. Llc | - | Sell | 13,726,411 | Common Stock, par value $0.01 per share | $15.90 | $218,249,934.90 | 238.75 [ Very High ] | 58,881,710 | $936,219,189.00 | 1,024.15 [Very High] | Form 4 | See Footnotes | 2019-06-13-04:00 | Thomas Connolly | - | Buy | 1,133,920 | Common Stock, par value $0.01 per share | $0.00 | $0.00 | - | 72,605,349 | $0.00 | 1,262.86 [Very High] | Form 4 | See Footnotes | 2020-05-26-04:00 | Thomas Connolly | - | Sell | 13,726,411 | Common Stock, par value $0.01 per share | $15.90 | $218,249,934.90 | 238.75 [ Very High ] | 58,881,710 | $936,219,189.00 | 1,024.15 [Very High] | Form 4 | See Footnotes | 2019-06-13-04:00 | Jo Natauri | - | Buy | 1,133,920 | Common Stock, par value $0.01 per share | $0.00 | $0.00 | - | 72,605,349 | $0.00 | 1,262.86 [Very High] | Form 4 | See Footnotes | 2020-05-26-04:00 | Jo Natauri | - | Sell | 13,726,411 | Common Stock, par value $0.01 per share | $15.90 | $218,249,934.90 | 238.75 [ Very High ] | 58,881,710 | $936,219,189.00 | 1,024.15 [Very High] | Form 4 | See Footnotes | 2020-05-08 | Gregory L Summe | - | Buy | 7,582 | Common Stock | $0.00 | $0.00 | - | 7,582 | $0.00 | 0.13 [Very Low] | Form 4 | - | 2020-04-24 | Eric Mcallister | EVP, CHRO | Sell | 8,975 | Common Stock | $14.04 | $126,009.00 | 0.16 [ Low ] | 207,054 | $2,907,038.16 | 3.60 [Low] | Form 4 | - | 2020-05-29 | Devashish Ohri | EVP, IMEA | Buy | 30,000 | Common Stock | $1.60 | -$48,000.00 | - | 181,671 | $290,673.60 | - | Form 4 | - | 2020-05-29 | Devashish Ohri | EVP, IMEA | Sell | 30,000 | Common Stock | $18.57 | $557,100.00 | - | 151,671 | $2,816,530.47 | - | Form 4 | - | 2020-05-29 | Devashish Ohri | EVP, IMEA | Buy | 35,000 | Common Stock | $1.60 | -$56,000.00 | - | 186,671 | $298,673.60 | - | Form 4 | - | 2020-05-29 | Devashish Ohri | EVP, IMEA | Sell | 35,000 | Common Stock | $19.07 | $667,450.00 | - | 151,671 | $2,892,365.97 | - | Form 4 | - | 2020-07-30 | Devashish Ohri | EVP, IMEA | Buy | 35,000 | Common Stock | $1.60 | -$56,000.00 | 0.61 [ Average ] | 186,671 | $298,673.60 | 3.24 [Low] | Form 4 | - | 2020-07-30 | Devashish Ohri | EVP, IMEA | Sell | 35,000 | Common Stock | $21.37 | $747,950.00 | 0.61 [ Average ] | 151,671 | $3,241,209.27 | 2.63 [Low] | Form 4 | - | 2020-08-19 | Rajiv Gupta | - | Buy | 1,147,970 | Common Stock | $1.60 | -$1,836,752.00 | 19.91 [ Very High ] | 1,856,716 | $2,970,745.60 | 32.20 [High] | Form 4 | - | 2020-08-19 | Rajiv Gupta | - | Sell | 100,000 | Common Stock | $0.00 | $0.00 | - | 1,756,716 | $0.00 | 30.47 [High] | Form 4 | - | 2020-08-21 | New Mountain Investments Iii, Llc | - | Sell | 25,575,472 | Common Stock | $19.51 | $498,977,458.72 | 443.54 [ Very High ] | 64,016,093 | $1,248,953,974.43 | 1,110.18 [Very High] | Form 4 | See Footnote | 2020-08-21-04:00 | Goldman Sachs & Co. Llc | - | Sell | 15,397,005 | Common Stock, par value $0.01 per share | $19.51 | $300,395,567.55 | 267.02 [ Very High ] | 43,483,708 | $848,367,143.08 | 754.11 [Very High] | Form 4 | See Footnotes | 2020-08-21-04:00 | Jo Natauri | - | Sell | 15,397,005 | Common Stock, par value $0.01 per share | $19.51 | $300,395,567.55 | 267.02 [ Very High ] | 43,483,708 | $848,367,143.08 | 754.11 [Very High] | Form 4 | See Footnotes | 2020-09-08 | Justin Miller | EVP & General Counsel | Sell | 22,887 | Common Stock | $21.17 | $484,517.79 | 0.40 [ Average ] | 113,507 | $2,402,943.19 | 1.97 [Low] | Form 4 | - | 2020-09-16 | Devashish Ohri | EVP, IMEA | Buy | 35,000 | Common Stock | $1.60 | -$56,000.00 | 0.61 [ Average ] | 186,671 | $298,673.60 | 3.24 [Low] | Form 4 | - | 2020-09-16 | Devashish Ohri | EVP, IMEA | Sell | 35,000 | Common Stock | $23.02 | $805,700.00 | 0.61 [ Average ] | 151,671 | $3,491,466.42 | 2.63 [Low] | Form 4 | - | 2020-10-05 | Devashish Ohri | EVP, IMEA | Buy | 18,440 | Common Stock | $1.60 | -$29,504.00 | 0.32 [ Average ] | 170,111 | $272,177.60 | 2.95 [Low] | Form 4 | - | 2020-10-05 | Devashish Ohri | EVP, IMEA | Sell | 18,440 | Common Stock | $23.53 | $433,893.20 | 0.32 [ Average ] | 151,671 | $3,568,818.63 | 2.63 [Low] | Form 4 | - | 2020-10-05 | Devashish Ohri | EVP, IMEA | Buy | 35,000 | Common Stock | $1.60 | -$56,000.00 | 0.61 [ Average ] | 186,671 | $298,673.60 | 3.24 [Low] | Form 4 | - | 2020-10-05 | Devashish Ohri | EVP, IMEA | Sell | 35,000 | Common Stock | $23.47 | $821,450.00 | 0.61 [ Average ] | 151,671 | $3,559,718.37 | 2.63 [Low] | Form 4 | - | 2020-10-05 | Devashish Ohri | EVP, IMEA | Buy | 50,000 | Common Stock | $1.60 | -$80,000.00 | 0.87 [ High ] | 201,671 | $322,673.60 | 3.50 [Low] | Form 4 | - | 2020-10-05 | Devashish Ohri | EVP, IMEA | Sell | 50,000 | Common Stock | $23.34 | $1,167,000.00 | 0.87 [ High ] | 151,671 | $3,540,001.14 | 2.63 [Low] | Form 4 | - | 2020-11-10 | New Mountain Investments Iii, Llc | - | Sell | 36,016,093 | Common Stock | $24.81 | $893,559,267.33 | 622.75 [ Very High ] | 28,000,000 | $694,680,000.00 | 484.15 [Very High] | Form 4 | See Footnote | 2020-12-04 | Michael Stubblefield | President and CEO | Buy | 880,601 | Common Stock | $1.60 | -$1,408,961.60 | 15.23 [ Very High ] | 2,147,536 | $3,436,057.60 | 37.13 [High] | Form 4 | - | 2020-12-04 | Michael Stubblefield | President and CEO | Sell | 412,188 | Common Stock | $27.08 | $11,162,051.04 | 7.13 [ Very High ] | 1,735,348 | $46,993,223.84 | 30.01 [High] | Form 4 | - | 2020-12-07 | Michael Stubblefield | President and CEO | Buy | 210,369 | Common Stock | $1.60 | -$336,590.40 | 3.64 [ Very High ] | 1,945,717 | $3,113,147.20 | 33.64 [High] | Form 4 | - | 2020-12-07 | Michael Stubblefield | President and CEO | Sell | 98,452 | Common Stock | $27.45 | $2,702,507.40 | 1.70 [ High ] | 1,847,265 | $50,707,424.25 | 31.94 [High] | Form 4 | - | 2020-12-21 | James Bramwell | EVP, Strategic Partners | Sell | 10,020 | Common Stock | $27.14 | $271,942.80 | 0.17 [ Low ] | 117,768 | $3,196,223.52 | 2.04 [Low] | Form 4 | - | 2021-01-02 | Thomas A Szlosek | EVP & CFO | Sell | 8,135 | Common Stock | $28.15 | $229,000.25 | 0.14 [ Low ] | 257,999 | $7,262,671.85 | 4.46 [Low] | Form 4 | - | 2020-12-31 | Steven W Eck | SVP & Chief Accounting Officer | Sell | 3,052 | Common Stock | $28.15 | $85,913.80 | 0.05 [ Very Low ] | 20,431 | $575,132.65 | 0.35 [Very Low] | Form 4 | - | 2021-01-02 | Michael Wondrasch | EVP & CIO | Sell | 4,083 | Common Stock | $28.15 | $114,936.45 | 0.07 [ Very Low ] | 149,974 | $4,221,768.10 | 2.59 [Low] | Form 4 | - | 2021-01-02 | Frederic Vanderhaegen | EVP, Europe | Sell | 1,017 | Common Stock | $28.15 | $28,628.55 | 0.02 [ Very Low ] | 236,414 | $6,655,054.10 | 4.09 [Low] | Form 4 | - | 2021-01-02 | Gerard Brophy | EVP, Biopharma Production | Sell | 6,559 | Common Stock | $28.15 | $184,635.85 | 0.11 [ Low ] | 190,024 | $5,349,175.60 | 3.29 [Low] | Form 4 | - | 2021-01-04 | Gerard Brophy | EVP, Biopharma Production | Buy | 59,418 | Common Stock | $18.45 | -$1,096,262.10 | 1.03 [ High ] | 249,442 | $4,602,204.90 | 4.31 [Low] | Form 4 | - | 2021-01-04 | Gerard Brophy | EVP, Biopharma Production | Sell | 59,418 | Common Stock | $27.84 | $1,654,197.12 | 1.03 [ High ] | 190,024 | $5,290,268.16 | 3.29 [Low] | Form 4 | - | 2020-12-31 | Sheri Lewis | EVP, Global Ops & Supply Chain | Buy | 53,286 | Common Stock | $0.00 | $0.00 | - | 53,286 | $0.00 | 0.92 [Very Low] | Form 4 | - | 2020-12-31 | Meghan Henson | EVP, Chief HR Officer | Buy | 17,762 | Common Stock | $0.00 | $0.00 | - | 17,762 | $0.00 | 0.31 [Very Low] | Form 4 | - | 2021-01-06 | Gerard Brophy | EVP, Biopharma Production | Sell | 11,509 | Common Stock | $27.24 | $313,505.16 | 0.20 [ Low ] | 178,515 | $4,862,748.60 | 3.09 [Low] | Form 4 | - | 2021-01-11 | Gerard Brophy | EVP, Biopharma Production | Buy | 216,332 | Common Stock | $23.20 | -$5,018,902.40 | 3.74 [ Very High ] | 394,847 | $9,160,450.40 | 6.83 [Average] | Form 4 | - | 2021-01-11 | Gerard Brophy | EVP, Biopharma Production | Sell | 216,332 | Common Stock | $30.08 | $6,507,266.56 | 3.74 [ Very High ] | 178,515 | $5,369,731.20 | 3.09 [Low] | Form 4 | - | 2021-01-11 | Gerard Brophy | EVP, Biopharma Production | Buy | 162,248 | Common Stock | $23.20 | -$3,764,153.60 | 2.81 [ Very High ] | 340,763 | $7,905,701.60 | 5.89 [Average] | Form 4 | - | 2021-01-11 | Gerard Brophy | EVP, Biopharma Production | Sell | 162,248 | Common Stock | $30.04 | $4,873,929.92 | 2.81 [ Very High ] | 178,515 | $5,362,590.60 | 3.09 [Low] | Form 4 | - | 2021-01-11 | James Bramwell | EVP, Strategic Partners | Sell | 2,505 | Common Stock | $30.00 | $75,150.00 | 0.04 [ Very Low ] | 116,430 | $3,492,900.00 | 2.01 [Low] | Form 4 | - | 2021-01-13 | Mark Christopher Murray | EVP, Biomaterials & AT | Sell | 918 | Common Stock | $29.20 | $26,805.60 | 0.02 [ Very Low ] | 11,458 | $334,573.60 | 0.20 [Very Low] | Form 4 | - | 2021-02-05 | Michael Wondrasch | EVP & CIO | Sell | 9,468 | Common Stock | $29.77 | $281,862.36 | 0.16 [ Low ] | 141,543 | $4,213,735.11 | 2.45 [Low] | Form 4 | - | 2021-02-05 | Michael Wondrasch | EVP & CIO | Buy | 40,000 | Common Stock | $23.20 | -$928,000.00 | 0.69 [ Average ] | 181,543 | $4,211,797.60 | 3.14 [Low] | Form 4 | - | 2021-02-05 | Michael Wondrasch | EVP & CIO | Sell | 40,000 | Common Stock | $29.77 | $1,190,800.00 | 0.69 [ Average ] | 141,543 | $4,213,735.11 | 2.45 [Low] | Form 4 | - | 2021-02-22 | Thomas A Szlosek | EVP & CFO | Sell | 2,980 | Common Stock | $28.69 | $85,496.20 | 0.05 [ Very Low ] | 256,374 | $7,355,370.06 | 4.41 [Low] | Form 4 | - | 2021-02-22 | Christophe Couturier | EVP, Services | Sell | 1,313 | Common Stock | $28.69 | $37,669.97 | 0.02 [ Very Low ] | 162,408 | $4,659,485.52 | 2.80 [Low] | Form 4 | - | 2021-02-22 | Devashish Ohri | EVP, IMEA | Sell | 1,210 | Common Stock | $28.69 | $34,714.90 | 0.02 [ Very Low ] | 150,461 | $4,316,726.09 | 2.59 [Low] | Form 4 | - | 2021-02-22 | James Bramwell | EVP, Strategic Partners | Sell | 1,216 | Common Stock | $28.69 | $34,887.04 | 0.02 [ Very Low ] | 115,214 | $3,305,489.66 | 1.98 [Low] | Form 4 | - | 2021-02-22 | Michael Stubblefield | President and CEO | Sell | 10,141 | Common Stock | $28.69 | $290,945.29 | 0.17 [ Low ] | 1,437,122 | $41,231,030.18 | 24.74 [High] | Form 4 | - | 2021-02-22 | Frederic Vanderhaegen | EVP, Europe | Sell | 398 | Common Stock | $28.69 | $11,418.62 | - | 237,388 | $6,810,661.72 | 4.09 [Low] | Form 4 | - | 2021-02-22 | Steven W Eck | SVP & Chief Accounting Officer | Sell | 449 | Common Stock | $28.69 | $12,881.81 | - | 19,982 | $573,283.58 | 0.34 [Very Low] | Form 4 | - | 2021-02-22 | Justin Miller | EVP & General Counsel | Sell | 1,350 | Common Stock | $28.69 | $38,731.50 | 0.02 [ Very Low ] | 113,434 | $3,254,421.46 | 1.95 [Low] | Form 4 | - | 2021-02-22 | Michael Wondrasch | EVP & CIO | Sell | 1,209 | Common Stock | $28.69 | $34,686.21 | 0.02 [ Very Low ] | 140,334 | $4,026,182.46 | 2.42 [Low] | Form 4 | - | 2021-02-22 | Gerard Brophy | EVP, Biopharma Production | Sell | 3,072 | Common Stock | $28.69 | $88,135.68 | 0.05 [ Very Low ] | 175,443 | $5,033,459.67 | 3.02 [Low] | Form 4 | - | 2021-02-22 | Gerard Brophy | EVP, Biopharma Production | Buy | 19,769 | Common Stock | $17.67 | -$349,318.23 | 0.34 [ Average ] | 195,212 | $3,449,396.04 | 3.36 [Low] | Form 4 | - | 2021-02-22 | Gerard Brophy | EVP, Biopharma Production | Sell | 19,769 | Common Stock | $28.62 | $565,788.78 | 0.34 [ Average ] | 175,443 | $5,021,178.66 | 3.02 [Low] | Form 4 | - | 2021-02-24 | Gerard Brophy | EVP, Biopharma Production | Sell | 3,059 | Common Stock | $27.93 | $85,437.87 | 0.05 [ Very Low ] | 172,384 | $4,814,685.12 | 2.97 [Low] | Form 4 | - | 2021-02-24 | Steven W Eck | SVP & Chief Accounting Officer | Buy | 8,550 | Common Stock | $0.00 | $0.00 | - | 28,532 | $0.00 | 0.49 [Very Low] | Form 4 | - | 2021-02-24 | Steven W Eck | SVP & Chief Accounting Officer | Sell | 2,577 | Common Stock | $27.94 | $72,001.38 | 0.04 [ Very Low ] | 25,955 | $725,182.70 | 0.45 [Very Low] | Form 4 | - | 2021-02-25 | Rajiv Gupta | - | Buy | 7,236 | Common Stock | $0.00 | $0.00 | - | 1,447,952 | $0.00 | 24.93 [High] | Form 4 | - | 2021-02-25 | Gregory L Summe | - | Buy | 7,236 | Common Stock | $0.00 | $0.00 | - | 14,818 | $0.00 | 0.26 [Very Low] | Form 4 | - | 2021-02-25 | Rakesh Sachdev | - | Buy | 7,236 | Common Stock | $0.00 | $0.00 | - | 32,841 | $0.00 | 0.57 [Very Low] | Form 4 | - | 2021-02-25 | Thomas A Szlosek | EVP & CFO | Buy | 16,281 | Common Stock | $0.00 | $0.00 | - | 272,655 | $0.00 | 4.69 [Average] | Form 4 | - | 2021-02-25 | Jonathan M Peacock | - | Buy | 7,236 | Common Stock | $0.00 | $0.00 | - | 168,431 | $0.00 | 2.90 [Low] | Form 4 | - | 2021-02-25 | Michael Severino | - | Buy | 7,236 | Common Stock | $0.00 | $0.00 | - | 17,258 | $0.00 | 0.30 [Very Low] | Form 4 | - | 2021-02-25 | Christophe Couturier | EVP, Services | Buy | 6,784 | Common Stock | $0.00 | $0.00 | - | 169,192 | $0.00 | - | Form 4 | - | 2021-02-25 | Christi Shaw | - | Buy | 7,236 | Common Stock | $0.00 | $0.00 | - | 18,555 | $0.00 | 0.32 [Very Low] | Form 4 | - | 2021-02-25 | Gerard Brophy | EVP, Biopharma Production | Buy | 16,281 | Common Stock | $0.00 | $0.00 | - | 188,665 | $0.00 | 3.25 [Low] | Form 4 | - | 2021-02-25 | Mark Christopher Murray | EVP, Biomaterials & AT | Buy | 8,140 | Common Stock | $0.00 | $0.00 | - | 19,598 | $0.00 | 0.34 [Very Low] | Form 4 | - | 2021-02-25 | Frederic Vanderhaegen | EVP, Europe | Buy | 16,281 | Common Stock | $0.00 | $0.00 | - | 253,669 | $0.00 | 4.37 [Low] | Form 4 | - | 2021-02-25 | Michael Wondrasch | EVP & CIO | Buy | 8,140 | Common Stock | $0.00 | $0.00 | - | 148,474 | $0.00 | 2.56 [Low] | Form 4 | - | 2021-02-25 | Justin Miller | EVP & General Counsel | Buy | 8,140 | Common Stock | $0.00 | $0.00 | - | 121,574 | $0.00 | 2.09 [Low] | Form 4 | - | 2021-02-25 | Meghan Henson | EVP, Chief HR Officer | Buy | 8,140 | Common Stock | $0.00 | $0.00 | - | 25,902 | $0.00 | 0.45 [Very Low] | Form 4 | - | 2021-02-25 | Devashish Ohri | EVP, IMEA | Buy | 5,427 | Common Stock | $0.00 | $0.00 | - | 155,888 | $0.00 | - | Form 4 | - | 2021-02-25 | James Bramwell | EVP, Strategic Partners | Buy | 5,427 | Common Stock | $0.00 | $0.00 | - | 120,641 | $0.00 | - | Form 4 | - | 2021-02-25 | Michael Stubblefield | President and CEO | Buy | 72,359 | Common Stock | $0.00 | $0.00 | - | 1,509,481 | $0.00 | - | Form 4 | - | 2021-02-25 | Sven Henrichwark | EVP, APAC Region | Buy | 5,427 | Common Stock | $0.00 | $0.00 | - | 19,802 | $0.00 | - | Form 4 | - | 2021-02-25 | Sheri Lewis | EVP, Global Ops & Supply Chain | Buy | 13,567 | Common Stock | $0.00 | $0.00 | - | 66,856 | $0.00 | - | Form 4 | - | 2021-02-25 | Juan Andres | - | Buy | 7,236 | Common Stock | $0.00 | $0.00 | - | 22,187 | $0.00 | - | Form 4 | - | 2021-02-25 | Steven W Eck | SVP & Chief Accounting Officer | Buy | 6,151 | Common Stock | $0.00 | $0.00 | - | 32,084 | $0.00 | - | Form 4 | - | 2021-03-02 | Michael Wondrasch | EVP & CIO | Sell | 3,036 | Common Stock | $28.71 | $87,163.56 | 0.05 [ Very Low ] | 145,438 | $4,175,524.98 | 2.50 [Low] | Form 4 | - | 2021-03-09 | Frederic Vanderhaegen | EVP, Europe | Sell | 10,000 | Common Stock | $28.21 | $282,100.00 | 0.17 [ Low ] | 243,669 | $6,873,902.49 | 4.20 [Low] | Form 4 | - | 2021-04-05 | Christophe Couturier | EVP, AMEA | Buy | 8,267 | Common Stock | $0.00 | $0.00 | - | 177,459 | $0.00 | 3.05 [Low] | Form 4 | - | 2021-04-12 | Justin Miller | EVP & General Counsel | Sell | 2,895 | Common Stock | $31.75 | $91,916.25 | 0.05 [ Very Low ] | 118,679 | $3,768,058.25 | 2.04 [Low] | Form 4 | - | 2021-04-12 | Justin Miller | EVP & General Counsel | Buy | 100,000 | Common Stock | $23.21 | -$2,321,000.00 | 1.72 [ High ] | 218,679 | $5,075,539.59 | 3.76 [Low] | Form 4 | - | 2021-04-12 | Justin Miller | EVP & General Counsel | Sell | 100,000 | Common Stock | $33.21 | $3,321,000.00 | 1.72 [ High ] | 118,679 | $3,941,329.59 | 2.04 [Low] | Form 4 | - | 2021-04-12 | James Bramwell | EVP, Strategic Partners | Sell | 2,505 | Common Stock | $32.00 | $80,160.00 | 0.04 [ Very Low ] | 118,136 | $3,780,352.00 | 2.03 [Low] | Form 4 | - | 2021-04-12 | Frederic Vanderhaegen | EVP, Europe | Sell | 10,000 | Common Stock | $31.75 | $317,500.00 | 0.17 [ Low ] | 233,669 | $7,418,990.75 | 4.02 [Low] | Form 4 | - | 2021-04-12 | Frederic Vanderhaegen | EVP, Europe | Sell | 17,075 | Common Stock | $31.83 | $543,497.25 | 0.29 [ Average ] | 216,594 | $6,894,187.02 | 3.72 [Low] | Form 4 | - | 2021-04-12 | Devashish Ohri | EVP, IMEA | Buy | 100,160 | Common Stock | $1.60 | -$160,256.00 | 1.72 [ High ] | 256,048 | $409,676.80 | 4.40 [Low] | Form 4 | - | 2021-04-12 | Devashish Ohri | EVP, IMEA | Sell | 100,160 | Common Stock | $32.37 | $3,242,179.20 | 1.72 [ High ] | 155,888 | $5,046,094.56 | 2.68 [Low] | Form 4 | - |
